Dr Heather Jim speaks with ecancertv at AACR 2016 about novel technologies in evaluating and integrating patient responses to therapies.
She describes how patient involvement has altered data acquisition and trial design, using technologies commonly available to patients at home with less cost and wider engagement than existing techniques.
With consideration of patients symptoms and response to therapies, Dr Jim hopes that novel technologies and even current wearable technologies could enable a more responsive, personalised care programme at low cost and significant benefit.
Notes
This material may be protected by copyright law (Title 17 U.S. Code).
Access-restricted-item
true
Addeddate
2019-12-01 13:54:36
Artist
Dr Heather Jim - Moffitt Cancer Center, Tampa, USA